CausesBy Mayo Clinic Staff
It's not clear what causes atypical hyperplasia.
Atypical hyperplasia forms when breast cells become abnormal in number, size, shape, growth pattern and appearance. The appearance of the abnormal cells determines the type of atypical hyperplasia:
- Atypical ductal hyperplasia causes abnormal cells that appear similar to the cells of the breast ducts.
- Atypical lobular hyperplasia causes abnormal cells that appear similar to the cells of the breast lobules.
Atypical hyperplasia is thought to be part of the complex transition of cells that may evolve into breast cancer. The progression to breast cancer typically involves:
Jan. 08, 2015
- Hyperplasia. The process begins when normal cell development and growth become disrupted, causing an overproduction of normal-looking cells (hyperplasia).
- Atypical hyperplasia. The excess cells stack upon one another and begin to take on an abnormal appearance. At this point, the cells have some, but not all, of the changes needed to become cancer.
- Noninvasive (in situ) cancer. The abnormal cells continue to progress in appearance and multiply, evolving into in situ cancer, in which cancer cells remain confined to the area where they start growing.
- Invasive cancer. Left untreated, the cancer cells may eventually become invasive cancer, invading surrounding tissue, blood vessels or lymph channels.
- Kumar V, et al. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Philadelphia, Pa.: Saunders Elsevier; 2015. http://www.clinicalkey.com. Accessed Aug. 21, 2014.
- AskMayoExpert. Atypical hyperplasia of the breast. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2014.
- Degnim AC, et al. Stratification of breast cancer risk in women with atypia: A Mayo cohort study. Journal of Clinical Oncology. 2007;25:2671.
- Breast cancer risk reduction. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Aug. 21, 2014.
- Breast cancer screening and diagnosis. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed Aug. 21, 2014.
- Pruthi S (expert opinion). Mayo Clinic, Rochester, Minn. Sept. 6, 2014.
- Hartmann LC, et al. Atypical hyperplasia of the breast — Risk assessment and management options. New England Journal of Medicine. 2015;372:78.
- Hartmann LC, et al. Understanding the premalignant potential of atypical hyperplasia through its natural history: A longitudinal cohort study. Cancer Prevention Research. 2014;7:211.